Only first 10,000 results will be saved in the file.
No item is selected. Use checkboxes to select search results.
Displaying 851-875 of 1083 results.
{{ selectedCountPage }} items selected on this page,{{ selectedCountPage }} item selected on this page,{{ selectedCountTotal }} item in total{{ selectedCountTotal }} items in total
Study aim:
Comparison between the efficacy of intravenous immunoglobulin and convalescent plasma in improving the condition of patients with COVID-19
Design:
clinical trial with control group- randomized- parallel groups
Settings and conduct:
This study is a clinical trial with control group that will be
Study aim:
the effectiveness of mindfulness-based stress reduction program on mental well-being, and quality of life of patients diagnosed with Covid-19 after discharge
Design:
a randomized clinical trial with a control group
A simple random sampling method and a quadruple block will be used for random
Study aim:
Determining the effectiveness of the intervention to improve the level of resilience of nurses working in the COVID-19 wards
Design:
Clinical trial with control group, parallel design, single (...) degree in nursing
• Work experience in the COVID-19 departments
. A resilience scores lower than 75 on
inactivated Covid-19 vaccines and at least two months have passed since the last injection; Not being infected with Covid-19 by using a rapid corona test and evaluating clinical symptoms.
Exclusion criteria: Having
involvement with infection, mood state, sleep quality of hospitalized patients with COVID-19 in the (...) software
Settings and conduct:
104 patients with covid-19 hospitalized in the non-special care department (...) with confirmed covid-19 in non-critical conditions and not hospitalized in the special care department
Study aim:
Evaluation of the effectiveness of the new formulation of antioxidant dietary supplement on the outcome (duration of discharge and death) of COVID-19 patients
Design:
Clinical trial with (...) groups of patients (non-critical :) with Covid-19 disease (group receiving complementary therapy and
Positive COVID-19 PCR ;
Women should not become pregnant for 30 days after the end of the study
patients (...) levamisole;
Use of drugs and antibiotics other than those used in the national COVID-19 treatment protocol
Study aim:
Safety and immunogenicity evaluation of mRNA-based COVID-19 vaccine (COReNAPCIN (...) substances; Positive PCR test of COVID-19 or influenza or symptoms consistent with these diseases; History of COVID-19 diagnosis within the last 3 months; Vulnerable groups and foreigners
Intervention groups
of vaccination, Occurrence of COVID-19 disease 2 weeks after 2nd vaccine dose: SAEs, SUSARs, MAAEs (...) Study aim:
Phase two of safety and immunogenicity of recombinant protein sub-unit Covid vaccine (...) ; Able to read and write; 18 - 70 years old; Negative RT-PCR tests for COVID, Negative S antibody titer
treatment of COVID-19
Design:
This study is a single-arm, uncontrolled, open-label clinical trial to evaluate the safety and efficacy of Remdesivir in COVID-19 patients.
Settings and conduct:
This (...) confirmed COVID-19 patients who are still progressing despite receiving standard treatment.
Exclusion
phones and at the end of surgery through the link sent Receive wound care and Covid-19 awareness. The (...) status. At the end of the surgery, the wound care and Covid-19 awareness will be sent to the mobile
Study aim:
Determining the combined effect of deep breathing and prone position on common respiratory symptoms in patients with COVID-19
Design:
Clinical trial without control group, with parallel, randomized groups, 96 patients
Settings and conduct:
Approval of the ethics committee. Complete the informed
caused by Covid19
Design:
Single-blind, randomized clinical trial without a control group, with (...) due to COVID-19 in the last 6 months and are eligible to be included and have a file in one of the (...) individuals who have experienced the death of a first-degree relative due to COVID19 during the last six
Study aim:
The effect of pirfenidone on prevention and treatment of pulmonary fibrosis and acute respiratory distress syndrome caused by COVID-19
Design:
Randomized clinical trial, with parallel (...) .
Participants/Inclusion and exclusion criteria:
Inclusion criteria
o Confirmed cases of COVID-19 who are 18
alleviate COVID-19 patients symptoms
Design:
Clinical trial with control group with parallel groups (...) .
Settings and conduct:
Available standard treatment (according to the latest protocol of the Covid-19(...) positive PCR test COVID-19 With inpatient clinical criteria (T>38°C or severe cough or shortness of breath
Study aim:
Comparing safety and efficacy of Favipiravir and Kaletra in COVID-19
Design:
Randomized (...) criteria:
Inclusion criteria: Diagnosis of COVID-19 based on either ground glass appearance in chest CT scan or positive RT-PCR test for COVID-19; Requiring hospitalization; Patient's age between 16 and 100
Study aim:
The aim of this study was to develop an analytical metacognitive therapy protocol using intervention mapping and its effect on my ability and reduce anxiety and depression of nurses involved with Covid-19 patients.
Design:
In the first stage, the intervention protocol is developed using cartography
problem inventory and covid-19 anxiety at the beginning of the intervention, 4 weeks after the beginning (...) criteria:
inclusion criteria: aged 19-45 years, more than five years of education, based on Beck's
Study aim:
The effect of family-centered empowerment model on stress, anxiety and family satisfaction in patients with Covid-19
Design:
Clinical trial with control group, with parallel groups,Two (...) will be performed on the families of patients with Quaid 19 disease referred to the 9th Di Torbat
Study aim:
The evaluation of efficacy and safety of Tocilizumab (AryoGen Pharmed Co.) in patients with severe COVID-19.
Design:
This is a phase III, open-label, and single-arm study with the sample (...) cities of Iran) clinical trial will be conducted in patients with COVID-19 with a follow-up duration of
performance, and quality of life in people with post-COVID-19 syndrome.
Design:
This study will be a blinded (...) fatigue and shortness of breath, after a period of infection with COVID-19 and at least 3 months have
Study aim:
The effect of spirulina platensis supplementation on disease severity and mortality in patients with coronavirus.
Design:
This clinical trial has parallel intervention and control group, open-label, randomized, multicenter, phase 3 on 240 patients. Random Allocation Software was used for randomization.
Settings and conduct:
The present study is an open-label clinical trial. The target population is patients hospitalized in the coronavirus ward of Ziaeian Hospital and Baharloo Hospital.
Participants/Inclusion and exclusion criteria:
Patients with coronavirus.
Inclusion criteria
1- Male and female patients, age ≥18.
2- The patient is stable in condition and does not need resuscitation.
3- Signed informed consent form.
4- Definitive/clinical diagnosis of coronavirus.
...
Exclusion criteria
1- Pregnancy or lactation.
2- Any history of drug allergy.
3- Active, clinically significant chronic illness or human immunodeficiency virus disease.
4- Significant organ dysfunctions such as renal failure, liver dysfunction, CHF, or serious and unstable cardiac condition.
...
Intervention groups:
Based on the entry criteria, patients who are eligible to enter the study are randomly divided into two intervention and control groups using the block randomization method. After obtaining consent from the patients, the intervention group will receive 15/2 g spirulina platensis algae powder daily.
Main outcome variables:
Reducing the severity of the disease and its mortality.
Study aim:
Comparison of the therapeutic effect of vitamin A and olfactory rehabilitation in improving anosmia, hypovasemia in patients with COVID-19 disease
Design:
This study is a controlled (...) Baqiyatallah Hospital. In this study, 90 positive Covid patients with anosmia and hyposemia for more than 2